ARGENVAC Vaccine Enters Final Phase of Testing on Humans, Developed by UNLP Scientists Docena and Azzaroni
Doctors Guillermo Docena and Omar Azzaroni, responsible for the development of ARGENVAC / UNLP ARGENVAC, the vaccine against SARS-CoV-2 developed by scientists at the National University of La Plata, has entered its final phase and only remains to be tested in humans. This was announced by the main people responsible for the project in a … Read more